Kininogen 1 (KNG1) Peptide
-
- Target See all KNG1 products
- KNG1 (Kininogen 1 (KNG1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- YPGKDFVQPP TKICVGCPRD IPTNSPELEE TLTHTITKLN AENNATFYFK
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KNG1 antibody,
Alternative Names: KNG1 control peptide, KNG1 antibody Blocking Peptide, Anti-KNG1 Blocking Peptide, Kininogen 1 Blocking Peptide, BDK Blocking Peptide, KNG Blocking Peptide, KNG1, KNG-1, KNG 1, KNG-1 Blocking Peptide, KNG 1 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- KNG1 (Kininogen 1 (KNG1))
- Background
- Kininogens are inhibitors of thiol proteases. HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII and inhibits the thrombin- and plasmin-induced aggregation of thrombocytes. The active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects such as influence in smooth muscle contraction, induction of hypotension, natriuresis and diuresis, etc.
- Molecular Weight
- 72 kDa
-